6th Drug Discovery Innovation Programme 29-30 November 2018 | Frankfurt, Germany

DDIP-Frankfurt-2018
DDIP-20186th Drug Discovery Innovation programme 29-30 November 2018, Leonardo Hotel Frankfurt City – South (Former Holiday Inn).

DDIP Is Exactly What The Pharma World Needs – A Level Eye Conference Between Big Pharma, Entrepreneurs And Academia Talking About Science And Technology.

This is a two days event, our professionals will be talking on new compounds, target validation and novel drug design methods and technologies.

Programme Highlights: Dualsystems-Biotech-AG-Dr-Paul-Helbling-CEO-2016

  • Target engagement
  • Advances in medicinal chemistry
  • Pre-clinical pharmacokinetics
  • Modern approaches for drug design
  • Role of AI in drug discovery
  • Open innovation
  • Computational approaches
  • Molecular dynamics
  • Biologics as potential therapeutics

Dr. Paul Helbling from Dualsystems Biotech AG is talking about LRC-TriCEPS target identification on living cells, so you can learn more about the new LRC-TriCEPS (Ligand-receptor capture) technology to identify targets and off-targets of your ligands on the living cells.

If you would like to meet Paul you can reach him via email paul.helbling@dualsystems.com or mobile +41 76 422 55 05

Meet Dr. Paul Helbling from Dualsystems Biotech AG to learn more about the LRC-TriCEPS (Ligand-receptor capture) technology to identify targets and off-targets of your ligands on the living cells.

Dr. Paul Helbling.
You can reach him via email
paul.helbling@dualsystems.com
or mobile +41 76 422 55 05

Paul Helbling- CEO Dualsystems Biotech AG - LinkedIn